MedTrace Logo

Combinations of Pharmacologic Smoking Cessation Treatments

NCT00018187 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL

Last updated 2009-01-21

No results posted yet for this study

Summary

The purpose of this study is to test the effectiveness of a combination of the drugs bupropion and mecamylamine along with a nicotine patch as a therapy for smoking cessation.

Conditions

  • Smoking

Interventions

DRUG

Bupropion

DRUG

Mecamylamine

DRUG

Nicotine Patch

Sponsors & Collaborators

Principal Investigators

  • Neil Hartman, M.D.

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1998-11-30
Completion
2001-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00018187 on ClinicalTrials.gov